In conclusion, B4GALNT2 and its cognate carbohydrate antigen Sda play a relevant role in CRC, not only for their association with better prognosis, but also because their expression is causally related to reduced malignancy in CRC experimental systems. The gene discussed is B4GALNT2; the disease is colorectal carcinoma.